REFERENCES
- Schilsky RL. Renal and metabolic toxicities of cancer chemotherapy. Semin Oncol 1982; 9: 75–83
- Adamson P C, Balis F M, Berg S, . General principles of chemotherapy. Principles and Practice of Pediatric Oncology, ed 5, PA Pizzo, DG Poplack, et al. Williams & Wilkins, Philadelphia 2006; 290–356
- Seidel H, Moe PJ, Nygaard R, et al. Evaluation of serious adverse events in patients treated with protocols including methotrexate infusions. Pediatr Hematol Oncol 1994; 11: 165–172
- Deray G, Khayat D, Cacoub P, et al. The effects of diltiazem on methotrexate-induced nephrotoxicity. Eur J Clin Pharmacol 1989; 37: 337–340
- Hempel L, Misselwitz J, Fleck C, et al. Influence of high dose methotrexate therapy on glomerular and tubular kidney function. Med Pediatr Oncol 2003; 40: 348–354
- Goren M P, Baker D K, Sheenep J L. Vancomycin does not enhance amikacin induced tubular nephrotoxicity in children. Pediatr Infect Dis J 1989; 8: 278–282
- Goren M P, Viar M J, Sheenep J L, et al. Monitoring serum aminoglycoside concentrations in children with amphotericine B nephrotoxicity. Pediatr Infect Dis J 1988; 7: 698–703
- Keeney R F, Kirk L E, Brigden D. Acyclovir tolerance in humans. Am J Med 1982; 73: 176–181
- Hovi L, Koskimies O, Holmberg C, et al. Risk of progressive kidney damage after acute leukemia. Acta Paediatr Scand 1989; 78: 608–614
- Yetgin S, Olgar Ş, Aras T, et al. Evaluation of kidney damage in patients with acute lymphoblastic leukemia in long term follow up: value of renal scan. Am J Hematol 2004; 77: 132–139
- Bardi E, Olah A V, Bartyik K, et al. Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatr Blood Cancer 2004; 43: 668–673
- Krawczuk-Rybak M, Kuzmicz M, Wysocka J. Renal function during and after treatment for acute lymphoblastic leukemia in children. Pediatr Nephrol 2005; 20: 782–785
- Kakihara T, Imai C, Hotta H, et al. Impaired tubular excretory function as a late renal side effect of chemotherapy in children. J Pediatr Hematol Oncol 2003; 25: 209–214
- Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995 Berlin-Frankfurt-Munster. Leukemia 2000; 14: 2205–2222
- Sikora P, Glatz S, Beck B B, et al. Urinary NAG in children with urolithiasis, nephrocalcinosis or risk of urolithiasis. Pediatr Nephrol 2003; 18: 996–999
- Weber M H, Verwiebe R. α1 Microglobulin (protein HC): features of a promising indicator of proximal tubular dysfunction. Eur J Clın Chem 1992; 30: 683–691
- Tomlinson PA. Low molecular weight proteins in children with renal disease. Pediatr Nephrol 1992; 6: 565–571
- Kinoshita A, Kurosawa Y, Kondoh K, et al. Effects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 2003; 51: 256–260
- Günel N, Coşkun U, Yamaç D, et al. Evaluation of serum cystatin C levels and 99 m technetium mercaptoacetyltriglycine-3 renal scintigraphy for the early detection of cisplatin induced renal toxicity in cancer patients. Nephrology 2002; 7: 56–60